The oncolytic virus has been shown to shrink colon, lung, breast, ovarian and pancreatic cancer tumors in preclinical laboratory models.

A blood test, combined with a risk model based on an individual’s history, more accurately determines who will benefit from screenings.

Virtual single-visit lung cancer screenings are just as effective as single-visit screenings done in person at the hospital.

Lung cancer can be elusive to spot and difficult to treat because the markers for it are found in other tissues, too.